We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The psychiatric side-effects of rimonabant.
- Authors
Moreira, Fabrício A; Crippa, José Alexandre S
- Abstract
Experimental evidence has suggested that drugs that enhance cannabinoid type-1 (CB1) receptor activity may induce anxiolytic and antidepressant effects, whilst the opposite has been reported with antagonists. Thus, the objective of the present review is to discuss the potential psychiatric side-effects of CB1 receptor antagonists, such as rimonabant, which has been recently marketed in several countries for the treatment of smoking cessation, obesity and associated metabolic disorders.
- Publication
Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2009, Vol 31, Issue 2, p145
- ISSN
1516-4446
- Publication type
Journal Article
- DOI
10.1590/s1516-44462009000200012